Sun Life Financial Inc. (SLF) Earnings Call Transcript & Summary

August 7, 2026

TSX CA Financials Insurance earnings 56 min

Earnings Call Speaker Segments

Operator

operator
#1

Good morning, and welcome to the Sun Life Financial Q2 2026 Conference Call. My name is Kai, and I will be your conference operator today. [Operator Instructions] The host of your call today is Natalie Brady, Senior Vice President, Capital Management and Investor Relations.

Natalie Brady

executive
#2

Thank you, and good morning, everyone. Welcome to Sun Life's Earnings Call for the second quarter of 2026. Or earnings release and the slides for today's call are available on the Investor Relations section of our website at sunlife.com. We'll begin today's call with opening remarks from Kevin Strain, President and Chief Executive Officer. Following Kevin Tim Deacon, Executive Vice President and Chief Financial Officer, will present the financial results for the quarter. After the prepared remarks, we will move to the question-and-answer portion of the call. Other members of management are also available to your questions this morning. Turning to Slide 2. I draw your attention to the cautionary language regarding the use of forward-looking statements and non-IFRS financial measures, which form of today's remarks. As noted on the slide forward-looking statements may be rendered inaccurate by subsequent events. And with that, I'll now turn things over to Kevin.

Kevin Strain

executive
#3

Thanks, Natalie, and good morning, everyone. Turning to Slide 5. We delivered strong second quarter results with double-digit underlying EPS growth reflecting higher earnings across our businesses and continued progress against our strategic priorities, strength in Canada, Asia and U.S., all contributed growth, while Asset Management continues to build moment Underlying net income was up from $1.02 billion last year. Underlying EPS was $2.02, up 13% over the prior year, and underlying return on equity was 19.1%. Reported net income was $1.01 billion compared with [ $716 ] million a year ago. Strong Protection earnings were driven by growth all insurance business in Canada delivered record results, reflecting strong business growth and favorable experience. In Asia, earnings increased from continued business growth. In the U.S., Health and Risk Solutions continue to perform well while management delivered strong earnings driven by favorable investments and insurance results. In Sun Life Asset Management, SLC Management earnings increased year-over-year supported by improved fundraising and deployment momentum while MFS delivered consistent earnings. We also delivered strong top line performance across the organization. Insurance sales increased 20% driven by growth in Asia and continued strength in the U.S. Asset Management net flows and net well sales improved by $16.3 billion, supported by strong private credit fundraising and a large mandate win in our DidaBirla Sunlight Asset Management business, the scale and brand recognition from this mandate amplifies our growth strategy for asset management in India. At MFS, out pools remain elevated, reflecting continued industry-wide pressure on active U.S. equity managers. Our capital position remains strong. We ended the quarter with ratio of 145% and holding company cash of $2.3 billion, reflecting the strength and resilience of our business. During the quarter, we renewed our normal course issuer bid to repurchase up to 10 million common shares and began purchasing shares under the program of our strong capital position and cash generation continue to provide flexibility to invest in our business while returning capital shareholders. Overall, this was a strong quarter that reflected the strength of our premise, our disciplined execution, our business growth across key markets and the resilience of our diversified model. Turning to Slide 6, let me touch on the 2 areas where we're seeing normal momentum for our digital transformation or -- we made significant progress this quarter. At an enterprise level, we recently announced our founding membership in an consortium along for Scotia Bank, TELUS and like AI consortium is a collaborative effort to build the infrastructure, governance and control needs to employ AI responsibly as scale in regulated industries. It is helping accelerate AI adoption in a way that is consistent with the government's standard clients and regulators expected while sharing costs with other major regulated Canadian institutions. In addition, to help technology architecture teams make informed decisions faster, we launch a new agentic AI platform. It has already freed up time by replacing the manual process of trade-off analysis was structured, data-driven and scalable decision making, beyond these enterprise initiatives, we're deploying AI solutions that deliver tangible benefits for clients and advisers. In Indonesia, we launched AI in our contact centers to enhance the client experience services through reducing advanced routing, analytics and monitoring capabilities to improve responsiveness and first call resolution. More broadly across Asia, we also launched tools in our agency channel that accelerate adviser onboarding in support of higher quality service through real-time coaching. Strengthening client interaction and enhancing the on-boarding experience. In Canada, we enhanced my Sun Life at with integrated health capabilities creating a more connected digital experience and bringing health benefits, services and support together in one place. We also launched AI-powered content for engine with the advisers faster access to information and the ability to address complex inquiries, helping advisers spend more time focused on advice and client relationships. Our responsible approach to AI is helping us improve client experiences, operating more efficiently and scale our businesses while keeping clients at the center. Turning to Asset and Wealth Management. We've now completed our first full quarter of Sun Life Asset Management operating a unified platform, we retain strong talent and we continue to deliver strong results to our clients and remain focused realizing the full potential of our combined capabilities, our strength in alternatives and our local expertise in new markets continue to be a driver of growth for Sun Life Asset Management. President proposed the largest direct lending in its history with $10.8 billion investment capital reflecting the strength of this platform and investor relation. President Pantheon also closed a USD 3.2 billion private credit continuation vehicle in the first half of the year, marking the larger transactions in the private credit secondaries market. In India Sun Life Asset Management on a large fixed income mandate for cosponsor doubling their assets under management to USD 113 billion. At MFS, when we continue prior active ETFs continue to gain traction generating inflows more than triple the prior year with AUM having now doubled since the start of 2026 to USD 3 million. In our Canadian business, wealth sales increased 6%, supported by record defined contribution sales strong overall activity and higher mutual fund sales. These examples show the scale and momentum we're building in asset management and the breadth of solutions that we're able to provide to a range of clients. Looking to Asia momentum accelerated across the region, sales increased 20% to $875 million, reflecting broad-based growth across the region. Hong Kong continued to perform well with sales increasing 20% driven by growth across all distribution channels and a 28% increase in advisers to Indonesia to nearly 4,000. Indonesia was another standard this quarter. Sales increased 69%, demonstrating the ongoing success of our expanded CIMB partnership. We also saw strong growth in India and Malaysia, reflecting attractive marketing vision and solid execution by our local teams. What stands out to me is the breadth of growth is coming from multiple markets in multichannel. That's important because great to a more resilient and higher-quality growth profile over time. As a result, total [indiscernible], up over 90% since the adoption of IFRS 17 and providing a strong foundation for future earnings growth. In the U.S., we delivered strong sales results and continued to expand services offered to our members. Medical stop-loss increased 86% over last year, reflecting disciplined pricing, strong underwriting and continued success in winning attractive business. We continue to benefit from our scale and capabilities in this market while maintaining our focus on risk-adjusted returns. This quarter, we expanded our suite of health solutions to provide differentiated support for employers and members through a new partnership we're providing access to clinical trials for people facing complex health conditions, enhancing the solutions available to support access to care, improve health outcomes and help people through series remains the more part of our strategy. In dental, we continue to focus on improving profitability through ongoing portfolio management activities across our government business, growth in our commercial business, disciplined expense management and continued execution while there's still work to do, we continue to make progress. Turning to Slide 7, we're continuing to perform well against our medium-term objectives. Underlying EPS growth was 13%, above our target of 10%. Underlying ROE was 19.1% in approaching our target of 20%, and our dividend ratio was 48% within our target range of 40% to 50%. Supported by these strong fundamentals are diversified business strategy, strength in both asset management and insurance and our industry-leading LICAT ratio, we remain well positioned to continue delivering sustainable broad-based earnings growth over the medium term. I'll now turn it over to Tim to go through the financials for the quarter.

Timothy Deacon

executive
#4

Thanks, Kevin, and good morning, everyone. Turning to Slide 9. We delivered strong second quarter results with underlying net income of $1.12 billion and underlying earnings per share of $2.02. Results were driven by strong contributions from Canada, Asia and the U.S. and continued momentum in Asset Management. Reported net income was $1.01 million. The difference between underlying and reported net income was primarily driven by acquisition and integration-related costs in SLC in the U.S., intangible asset amortization and modestly unfavorable net market impacts. Market impacts reflected yield curve movements during the quarter, real estate returns that were positive but below long-term expectations and strong public equity market performance in the quarter. Turning to Slide 10. Sun Life Asset management underlying net income of [USD 252 ] million increased 4% year-over-year, mainly driven by earnings growth at SLC, favorable seed investment performance and disciplined expense management improved fee-related earnings margins in the quarter. At MFS, higher average net assets supported earnings growth and profit margins improved by 0.6% despite continued rate price. Reported net income increased 14% from market experience at SLC and also reflects the offsetting impact of accelerated amortization of certain compensation expenses for retirement eligible employees in and a gain on the sale back of posting funds. The compensation item reflects the timing and recognition of expenses rather than the change in total compensation cost. Capital raising of USD 4.7 in deployment activity of USD 6.2 billion remains strong across the platform, up 8% and 42%, respectively, particularly with enter private credit and fixed income strategies. MFS continued to experience net outflows for Q2 from increased industry-wide sure on active equity managers from the increasing popularity of lower tracking error strategies. In parallel, the business continues to see momentum in ETF businesses with $0.6 billion of retail inflows and 2 new ETF launches this quarter alongside continued growth in fixed income and retail SMA products. Turning to Slide 11. Canada, underlying net income of $427 million, a new record increased 23% from the prior year. Favorable insurance experience was a significant contributor to earnings in the quarter, reflecting post and sustainable benefits from the investments we've made over time in our people, processes and capabilities. Canada's Wealth businesses increased underlying earnings by over 19%, driven by growth in AUM. Reported net income of $443 million reflects favorable market-related impacts. Canada's Wealth platform reached $286 billion in assets under management and administration, up 18% from last year as a result of record sales in the defined contribution business, increased in the rollover business and strong equity market performance. Insurance sales were broadly consistent with the prior year in both Sun Life health and individual insurance, reflecting the timing of large deals and sales. Turning to Slide 12. We're demonstrating solid progress and growth in our U.S. business. Underlying net income increased 15%, driven by business growth in medical stop-loss earnings and favorable investment results in insurance experience in the in-force management. Reported net income increased 69% from the prior year driven by a prior year intangible impairment charge in [indiscernible] and the increase in net income. In stop loss, sales increased 86% year-over-year, reflecting strong close ratios and pricing discipline, supported by our risk selection approach. Growth continues to be supported by our differentiated health and solutions, advanced analytics capabilities and continued focus on risk selection. In dental, we continued to reposition the business by improving pricing, exiting unprofitable contracts optimizing our expense base and growing our commercial dental business. These actions contributed to improved loss ratios this quarter. Medicaid membership declined 9%, reflecting our deliberate actions to terminate unprofitable contracts as well as ongoing industry-wide dynamics. Commercial dental sales increased 10% in the quarter, reflecting progress in building a stronger business mix, as we continue to kind of execute against these priorities, we expect gradual improvement in earnings over time. Turning to Slide 13. Asia had another outstanding quarter with underlying net income increasing 21% over the prior year driven by robust organic CSM growth, lower expenses and improved credit experience. Reported net income increased 158% from the prior year, driven by market-related impacts and the increase in underlying net income. Asia individual's Insurance sales of $875 million, were up 20%, primarily from strong growth across Hong Kong and our bancassurance channels in India, Malaysia and in Indonesia. Hong Kong delivered insurance sales growth of 20% year-over-year across panels supported by expansion of the adviser force by 28% to nearly 4,000 advisers. Indonesia, to 69% sales growth, reflecting the continued momentum from our bank insurance partnership with CIMB Niaga. Our business SM declined year-over-year, primarily reflecting the competitive environment in Hong Kong, although margins were lower than a year ago, they remain strong. Turning to our capital position on Slide 14. We ended the quarter with a LICAT ratio of 145%, which increased 2 percentage points over the prior quarter, mainly driven by $750 million sub debt issuance at the lowest spread 7-year issuance in the Canadian financial sector in the last 25 years. This is a testament to the quality of Sun Life in debt markets. We delivered book value per share growth of 3% to and finished the quarter with a financial leverage ratio of 23.8%. Organic capital generation was 41%, which exceeded their 30% to 40% range of guidance. Total CSM of [ $15.3 billion ] increase 12% over Q2 last year, driven by strong insurance sales. Together, these metrics reinforce our financial strength and provide resilience in more volatile areas. Turning to Slide 15. In the quarter, we returned $0.5 billion to shareholders through common shareholder dividends, delivering a dividend yield of 3.8%. We also renewed our normal course issuer bid to repurchase up to 10 million shares in June, and we purchased 0.8 million shares to date under the program. In closing, we are very pleased with our second quarter results, which demonstrate the earnings power of our business. Our strong balance sheet and capital position provides flexibility to invest in growth, to support our clients and return capital to shareholders. Looking ahead, we remain focused on executing our client impact strategy and delivering sustainable long-term value for shareholders. With that, I'll turn it back to Kevin for some closing remarks.

Kevin Strain

executive
#5

Thanks, Tim. As I mark 5 years as CEO, I see this quarter is another proof point of our work to build a more diversified go and growth-oriented Sun Life. The company delivered strong earnings growth in line with medium-term objectives. Our diversified global business, strong capital position and disciplined execution continued to enable progress in areas that matter most for long-term value creation. Across our organization, we remain anchored by our purpose of helping clients achieve lifetime pension security and live healthier lives. Broad-based growth across Canada, Asia and U.S. Health and Risk Solutions, combined with accelerating asset management momentum is showing up clearly in earnings growth. We remain confident in our ability to continue creating sustainable value for clients and shareholders. With that, I'll turn it over to Natalie for the Q&A portion.

Natalie Brady

executive
#6

[Operator Instructions] I will now ask the operator to hold the participants.

Operator

operator
#7

[Operator Instructions] The first question question comes from Gabriel Dechain National Bank .

Gabriel Dechaine

analyst
#8

My question is on the U.S. business, both the proof and the dental stop-loss, if we get in the page on the slide, this is an unfavorable experience due to seasonal reserve build kind of the phrasing of that seems like odd. And if it's seasonal, wouldn't you have kind of anticipated that? Or is there actually a variance here versus what you normally do because everybody is focused on the stop-loss stuff.

Unknown Executive

executive
#9

New results do include on seasonality in the buildup, that is reserves. That is a what is in that on [indiscernible] you can consider a expected. And the expense is still in line with our expectations despite this and so more busy in Warner was impacted -- it was mostly because of the mill while target loss ratios, the more an experience overall is a little bit higher in that unexpected line than a year ago, just reflecting the larger book due to the stronger growth year-over-year over the past several quarters. The loss ratios remained stable within our target range and very strong results overall the stop-loss business continues to perform very well and in line with our expectations.

Gabriel Dechaine

analyst
#10

I guess you said it I don't quite get that, unfavorable but expected. If it is expected. Why is it unfavorable lower short-term insurance profit number in the quarter or something like that?

Unknown Executive

executive
#11

I mean, our reserves do build over the course of the year just because payout at the same time the premiums come in. So it's just a matter of time...

Gabriel Dechaine

analyst
#12

I get that it's you would have and we can move on. The dental business, I understand the strategy there. You clearly articulated that. I just want to get a sense for more business is there to shed? And what's the time line for that -- the intermediated or brokered business?

Unknown Executive

executive
#13

Yes. So as was noted in the internal results for pressure in the quarter were done by lower membership, which was down 9% year-over-year. We are making progress in dental and our pricing discipline on new business and decisions to exit on profitable existing business are driving improvements in the loss ratio. But as you noted, there are those ongoing volume headwinds in our Medicaid dental business, and that's consistent with the broader market, which will suppress that earning this year. We remain focused on shifting towards more profitable mix as we then local business and our commercial dental. And then our broader plans of course includes optimizing your spend space and continue to some discipline in expense management. So we expect these actions to start to shift our business mix over to more stable, higher-quality earnings space over the next 1 to 2 years?

Gabriel Dechaine

analyst
#14

Yes, yes, no, I understand the strategy and you're articulating in just next quarter, the Medicaid premiums dropped $150 million or -- I'm just making up a number, but people have to kind of get a sense of the glide path here. So we can avoid negative surprises. I don't know if you can give a sense that in that direction or the timing of it? in 1 or 2 years, sure, but I wonder to you or how much of this business is going to be shifted away?

Unknown Executive

executive
#15

Yes, it's a good question. I mean the activities that we are taking on likely offset the Medicaid volume-related pressures we're seeing over the near term. And as a reminder, Q3 is seasonally the highest quarter for utilization in the year prior to the start of the year and then Q4 is relatively lower quarter in utilization quarter. So we do expect the membership to remain lower this year. And then we're looking ahead to the broader market dynamic center in '27.

Kevin Strain

executive
#16

It's Kevin. Maybe just add a quick thing on this. I watched David and his team and they're fixing the fundamentals of the state business, but it is going to be fundamentally a smaller part of what we do on the dental side and building out the commercial, which is going to take a number of years to build the commercial, but ther is more and more focus on that in on the commercial side of the dental business. And I'd also say on the overall U.S. results were really strong in the quarter, and it reflects what David and the team are doing to build that out. And exactly what we said what happened on stop-loss. We were we were seeing the pricing hardening, and we were winning more of that, and it's coming in at on the ratios. So I'm actually quite pleased with how the stop-loss and the benefits business is doing, and I'm pleased with the progress on the dental side. The state business is going to be a struggle for a number of years, and the focus is shifting over to the commercial side. And that's very clear and is very deliberate and I see them making progress there, and that's where measuring the progress. I wouldn't have high expectations of the state business for a number of years because it's a number of years building it out.

Operator

operator
#17

Our next question is from Mike Ward with UBS.

Michael Ward

analyst
#18

I'm just wondering if you could discuss the stop-loss sales result, just thought that was super strong. And I just -- I've got to imagine you guys are pretty confident on the margins on new and renewal business. So I'm just wondering if you could kind of characterize the competitive environment. And is it easier to win new business given hard market and some people are pulling back? Or are you being more aggressive in growth?

David Healy

executive
#19

Thanks for the question. So we, first of all, remain diligent and disciplined in a rising underwriting approach, which has led to our scale and leading market position, and we certainly are benefiting from all the work we're doing in underwriting in advancing in our decision-making, our differentiated health capabilities here are also notable because that focus on cost containment is increasingly resonating in the market as employers are more focused than ever in the waste management. We are benefiting from a continued hard market and our approach in rating and underwriting a lot of what those capabilities really position us well over the longer term. But in terms of margins, we remain focused on our margins and we have that discipline approached. If you look at our performance over the last little while, the 125 cohort is now largely complete, it is 97% complete and in line with our expectations, and we continue to get the pricing on our '26 business. It's probably worth noting that sales is '25 were little lower than our typical growth rate due to what we competitive pressures at the time and now as I said, the market has been in the year since '26.

Michael Ward

analyst
#20

That's helpful. And then I was wondering in Asia, could you discuss the sustainability of the strength there? And maybe thoughts on the kind of focus on the MCV business in Hong Kong by China?

Unknown Executive

executive
#21

Mike, it's Matt. Maybe I'll start with your second question. So in terms of the Hong Kong business. Let me just start with a bit of context on that business. As you've seen the business has delivered exceptional performance over the last few years. In fact, we've outperformed our peers and we gained market share over that period. And that's been supported by delivering investments we've made in distribution, brand, talent and IT as well as storm execution. Some of the fundamentals of the business are very strong. And we have a very diversified business across all dimensions and distribution, we sell for bank, broker and agency. We provide client solutions to meet protection, savings and retirement needs and our clients include local Hong Kong clients from South-East Asia and MCI. In terms of the MCI client base that makes up roughly about 30% of our overall base in Hong Kong. And obviously, that will change a little bit quarter-to-quarter depending on the mix. And in terms of how we serve that client base. I mean we really are focused on providing specific needs for them and that includes hires return diversification of investments as well as access to products to help them with legacy planning and wealth preservation needs. So I know there's some focus on the tax element in this, but that hasn't really been the key focus of what they're looking for when they come and talk to us. So quite fundamentally, I think the business is in very good shape. And I feel that we have good momentum and that will continue.

Operator

operator
#22

The next question is from Doug Young with Desjardins.

Doug Young

analyst
#23

Maybe just going to annealing talk a little bit about the experience this quarter, which was favorable in as been in the past. It is noticeably improve the PAA growth. And then I mean general, Canada is generating, I think, year-to-date, about 34% ROE. I guess there's the mission punching above its weight or just trying to get a sense of the sustainability of this because it is a big part of the Sun Life story.

Unknown Executive

executive
#24

It's Jessica. Thank you maybe let me talk about the insurance experience in this particular quarter, and then I'll talk a bit about most sustainability and [indiscernible] cause. So I think from this quarter, you see experience gains, about 1/3 of that is from mortality and then 2/3 is morbidity. And I think from the mobility standpoint, we benefit from actually sustained and very purposeful investments in people, processes and capabilities such that not only we have actually low claims volumes or the claims duration, but also while maintaining pricing discipline to be competitive as well. So some of the things that we have taken to kind of get the sustained results would be things for example, is not just individual case managers, but it's actually an integrated case management team actually helps position us. We may actually a lot of significant investments in different payments between different cases and then you have different nudges and different experience that the members has been navigated through this sort of difficult journey that they are able to do that seamlessly. So like digital forms the health of petition is, we actually made a lot of investments to reduce that. We have tailored nudges helping actually help position us to nudge so that they will be better in the recovery journey. So these are things that we have been purposefully doing for the past few years, which is why you see this. And then zooming out on sustainability, if you look at the past 8 quarters, we had a positive insurance experience on average about $57 million every quarter pretax. I think that something that is quite sustainable. It is as reflected because we been very disciplined on what we write in the -- risk adjustments are solid. And then I think one variation on the quarter -- we do expect to continue very evermore to have a positive experience in the insurance side. And then I think maybe one more point while if you zoom out beyond the experience you hear from Tim's opening remarks, that actually, if you look at this half of the year overall Canada has actually improved its earnings by 15%. Only 5% of that is actually from the insurance experience and the remaining 10% gained from actually a strong growth on all 3 parts of our businesses. Insurance grew at 6% in CSM and continue strong growth. Health you look at the other insurance line actually grew by 11%. And then most importantly, I think our wellness management business that Tim eluted to is now [ $ 286 billion ] of AUMA in in this half of the year went up by 26%, 18% of which is credited to both favorable market but also positive in those. this quarter we have $1.4 billion of net inflows. And then the other kind of remaining 7% growth due to efficiencies in the economies of sales, which you would expect as you go in wealth asset management that we benefit from the scale that we get. So I think sustainability wise, we're very confident that Canada is punching [indiscernible] medium term objective.

Doug Young

analyst
#25

Just one quick one, Tim, the U.S. $350 million price per sell, net 80% of that has been settled in stock in Q3. I've seen that side of big stock price or share price has gone up a lot, just kind of curious that assume that stock price that was set up, just want to clarify.

Timothy Deacon

executive
#26

This is Tim. You correct acquisition we completed that at the beginning of July, and almost 80% of that purchase price was made in shares. And it was based on the 20 days leading up to the closing price on the average share price in that period. That was just shy of $400 million overall for total purchase and it was about $3.6 million shares. But that's an issue in complete in Q2.

Doug Young

analyst
#27

And that is in W3.

Timothy Deacon

executive
#28

Yes, it will show up in Q3, it is an subsequent events in our financials, but because it closed in July, yes we'll start to pick up the earnings of that business in the third quarter.

Operator

operator
#29

Next question is from David Andrich with Jefferies.

Unknown Analyst

analyst
#30

Just want to follow up on Doug's question around the experience gains in Canada. And just based upon the response, it sounds like you're kind of expecting the positive trend to continue to see that come through? And then the second part to that was some of your peers have experienced some headwinds from a long-term disability experience and just there doesn't seem to be anything coming in your results. So I'm just wondering if you could comment on that on your experience specificially.

Unknown Executive

executive
#31

We do expect that I think the insurance experience line continue to I mean there will be fluctuations quarter-on-quarter due to season and other sectors. As I mentioned, if you look at the past quarters, doesn't matter which period you look average is about $57 million pretax, is $41 million post tax. So I think that will be fluctuations in every quarter, but I think that we expect to be continuing to have that positive number. And then I think in terms of the long term trends. I think there's -- some of the trends in the market has been there for quite some time. For example, I think since COVID, we've already had 40% of the claims due to mental wellness and stuff. So that's something new. And I think this is one that all in the industries have been diligently working on. And I think the long-term kind of results, I think one is about pricing discipline, while remaining competitive and that's the one that we try to do. And then two, as I mentioned, because of the short and the long-term visibility we about multiyear journey. These are purposeful and sustained investments. It's not one single thing, but it's really 1 of the things I described about the people, the processes and the capabilities that we've made investments across. So for example, one of the things that I think to help improve the outcomes for our members is this year, last year, we had a pilot for all of Ontario on disability management of 20% of our business, there were some of the technical platform and processes and that I just mentioned. And this year, we start roll out to the whole country. So I think we'll continue to be diligent and helping our members get to better outcomes.p

Operator

operator
#32

The next question is from Nick Lu with Evercore.

Nick Lu

analyst
#33

My first one was a quick follow up on Asia. I read the earlier comment as in the MCV business represents about 30% of total sales on Hong Kong. And I will have the local bancassurance partners been reacting to the ones on taxes or the broader cross-border capital flow?

Manjit Singh

executive
#34

Nike yes, you're correct. It's starting figure 30% of the long-term sales. I think in terms bank insurance partners, we have a very strong bank insurance agreement with Dosing. I think, obviously, some of the new requirements put in place if there's sort of even more diligence that all banks are putting on in terms of account openings and we're seeing that across the industry.

Nick Lu

analyst
#35

And my followup was on stop-loss business in the U.S. Are we at a stage where you think you have an early view to what kind of rate increases going in to -- that you think will be going to [indiscernible] million on your large U.S. peers also noted some favorable experience on '26 but relative to '24 and '25 and was wondering if you are in something directionally responsible.

David Healy

executive
#36

It's David. Thanks for the question. Yes. So obviously, we're landing very carefully the emergence of experience on cohort, we are still early in that process. It's about 15% complete. Our underlying technical analysis and underlying margin and actual experience are starting giving us confidence in terms of operating approach and how we are approaching that, but we'll continue to monetize the dynamic change in the course of the year and we remain very focused and very confident based on our proprietary and risk evaluation, that we'll continue to focus on that as we -- as the year progresses.

Operator

operator
#37

Te next question is from Paul Holden with CIBC.

Paul Holden

analyst
#38

I want to continue with the line of questioning on stock loss. So premiums are up 25% year-over-year. You say that margins or loss ratios is in line with your expectation. I would have expected these on the top line growth? And then I don't know if it's stable to improving margins that you would have seen more of an earnings lift, right? Like that's the way the basic math should work. So unless you're getting more conservative on IBNR, I'm not really sure why we're not seeing more earnings growth salons? Maybe help us address that for us.

Unknown Executive

executive
#39

Certainly, we're benefiting from the momentum we have both in sales and persistency in our solid earnings result. Obviously, in our benefits business overall, we also have our employee benefits business. When you look at that portion of the business, it is down from what was a record quarter in Q2 of 2025, where we saw really very favorable disability experience and consistent with broader industry trends and sort of reverting back to more or we expect to be normal trends in work in the foreseeable future, and we're paying close attention to those. But they are all in our health rentals overall. But we're very confident in our position, and we remain very diligent in our approach with stop-loss and we need to monitor how this year progress .

Paul Holden

analyst
#40

So what you're suggesting is you are seeing good earnings growth and stock loss is just not by lower earnings in the employee benefit business?

Unknown Executive

executive
#41

Yes. Again, we did have really a record quarter in the Q2 of '25 , and that was partially on the back of really great experience, and there was some also onetime items in there that did not recur this year.

Paul Holden

analyst
#42

Got it. I wanted to ask a question on Asia. So I guess for Manjit. So another quarter of strong APE sales, I think, 19% overall. But then when I looked at the new business, CSM, I think it was actually down every year-over-year and down 7%. So maybe you can help us understand the disconnect there.

Manjit Singh

executive
#43

So maybe just again, I'll zoom out a bit and then come to your questions. So if you look at it over the last 2 years, we've delivered very -- delivered very strong new business CSM growth infact over year period, we delivered over $2 billion in new business CSM. And we've had exceptional performance last year, as you recall, some of that was you did some tailwinds you were experiencing with some of the proposed regulation changes that pulled in the volume and that volume you saw an increase in new business margins and with that behind us, those margins and EBITDA, which is why you're seeing a relative evening out of the new business CSM margins. On an overall nominal level, we still generated $277 million in new business CSM. I'm very pleased with those levels, and those levels will support ongoing earnings growth.

Paul Holden

analyst
#44

Okay. So I try to unpack that then is kind of a little bit of expenses may be catching up the volumes because volumes again still higher. So I don't know if it is expenses growing or mix changing?

Manjit Singh

executive
#45

Yes, I think it's a bit of mix, but it's also for the level of when we're growing our expenses as well. But we got higher volumes last year relative to the expense base that we had.

Operator

operator
#46

The next question is from Tom MacKinnon with BMO Capital.

Tom MacKinnon

analyst
#47

Two questions. First one just with respect to your net worth business there. I mean underlying earnings sales were up nicely in the second quarter. Maybe you can in what proportion these high network clients just maybe in terms of the dollar amount sales would be from China and what may be impact as a result of some of the offshore trust implications that we're seeing out of China and offshore investments would not have made any impact on the continued momentum we're seeing here and my net worth of sales and earnings in that.

Manjit Singh

executive
#48

For that business, it's actually a lower proportion than I referenced earlier for Hong Kong. For high-network business as an international business and including clients from Southeast Asia or the Middle East -- other parts of Asia, MCI is really only about 10% of that business. So overall, I don't expect that to have a material impact on the contributions of the high network business.

Tom MacKinnon

analyst
#49

Okay. And then just with respect to SLC. Our addition here, I think you've talked about 20% medium term outlook for underlying earning in that business. But if I look at the quarter here, loans are better, but the related revenue, the related earnings are going flat year-over-year. What would you point to, to give you confidence that the setup here is good and that we should be able to by 2027 starting to get most of this 20% growth that you're talking about. What would you tell investors to look for with respect to SLC.

Stephen Peacher

executive
#50

Well, at the end of the day, I think this business is driven by is not surprising, but first and foremost, driven by having strong performance and the strategy that the market was saying, and then that manifests itself in growing positive as well as growing AUM. And if you do that in 1 ecobaging your expense base, you're going to have growing profits. And I think if you think about the underlying drug, if you think about more categories where we have strategies across real estate, private credit in different form and different geographies and infrastructure, all those have -- all those are growing categories in the institutional space. And of course, we haven't raised significant money in the well space, but it's a big priority. And we think it is going to be a huge driver of loans over the coming years in the well space and we've got the products and we put the distribution in place and we think we're going to benefit that -- benfit from that. The other thing that -- so we've got underlying tailwinds. We feel like we've got the right products, and we feel like wealth is going to kick in over the coming years. The other thing is internally until in the call in March, this SLC was really a collection of business side by side operating independently and that was very intentional because as we bought BGO as we bought, as we invested in [indiscernible], it was very important, in my view, and I think it summize you that we demonstrate to the employees and to their clients that we are going to let those teams standard business exactly the way Sun Life heads management business for the last 40 years. Now that those put calls are done, all the employee incentives are aligned in the SLC level right next to Sun Life, we can now operate as a and enterprise. And we think on the -- internally that's going to allow us to pursue expense efficiencies that we haven't spent any time pursuing until now. Also, I think as we present ourselves in the market and we present ourselves as a platform like a Blackstone or like an Apollo or like in Ares, we think that's going to be an accelerated growth as well. We've got institutional clients who've invested in BGO and who've invested with Crescent. And I'm not 1 surely know that those 2 companies are connected because we have an appropriate way and now we can more 4 months into that, we're moving as quickly as possible. We thinking about how we combine distribution systems, we're thinking about branding, et cetera. So I think that's going to be an accelerated growth as well.

Tom MacKinnon

analyst
#51

So to paraphrase, it seems asset growth and net would be flow. So would you expect the second half of '26 be better than the [ $8 billion ] net inflows on the half of 2025. And then with respect to efficiency, should we be looking for the pretax net operating margin to start picking up, it has been any kind of flat way over the last 4 quarters.

Stephen Peacher

executive
#52

Yes. Well, I would say on the quarterly flows, we would expect -- I think you've got to look at this over a multiyear basis because our business is largely institutional, which means our quarterly flows are significantly based on when you have fund closes. For example, in this quarter, I think as Kevin mentioned, we had a big close and we'll call CDL -- Crescent CDL, Crescent direct lending flow that was a big factor in this quarter. And those can be lumpy. Some of your flows and your fundraising change a lot quarter-to-quarter by asset class and can be lumpy. But I think if you follow us over the next -- throughout this year, but also with '27 and '28, I would strongly expect pickup in those flows quarter-to-quarter as we grow the business and we grow AUM. We also fully expect that margins should expand significantly, partly as we grow AUM we should -- the benefits of scale, but also now that we can operate an enterprise we think we can become more efficient from an extension standpoint. So we -- I think we put in our midterm targets that we would expect margins to expand significantly over the coming years.

Tom MacKinnon

analyst
#53

Is there any margin target that you had given to remind us that?

Stephen Peacher

executive
#54

We expect operating margin to be over 30% over the coming years. So I don't -- if you look over the next 5 years, I would expect that to be in the mid-30% range or higher.

Operator

operator
#55

The next question is from Mario Mendonca with TD Securities.

Mario Mendonca

analyst
#56

You're answering one of the questions. Did you lay out the proportion of Hong Kong sales that related MCD?

Unknown Executive

executive
#57

Yes, Mario, it was 30%.

Mario Mendonca

analyst
#58

And then, in response to Paul's question. I think I understand your answer, but I want to just follow up with something. When you see the decline in CSM generated in the quarter relative to the sales and it makes me think the pricing environment, the pricing was different this quarter from the previous year. So where I'm going with this is, were there any pricing concessions or specials on particular products in order? And if there were, why did you feel the need to do that in this quarter?

Unknown Executive

executive
#59

Yes. I think it's the year-over-year thing, so it wasn't necessarily particular to this quarter. I think our products evolve over time there over the last year. We've introduced the products over that period and different products we're selling with different features. And those have an impact on margins. I think if you go back and you look at the overall margins we're generating, we're still generating mid-30% margins, which are delivering the lift in roe you're seeing and so we're very pleased with the product line that we have.

Kevin Strain

executive
#60

Sorry, it's Kevin. I just might add, like Hong Kong is a very competitive market you've got. The world's leading insurers that Manjit and team are competing with. And we've made up a lot of room in terms of our size in the Hong Kong market over the last few years, which means that we are -- sometimes we're even the target now of competitors that are looking at it. So if -- we have to do what it takes to continue to grow profitably there and I think Manjit has done that and the profitability is still really good, it was even better probably 12 months ago, but it's still very strong, and we're still very pleased with the growth. And remember that, our growth there is quite diversified. We continue to grow our agency, we continue to grow in the bancassurance channel, and we continue to grow with brokers. And I think that diversification of Hong Kong nationals, Mainland Chinese visitors, but also people from other parts of Asia that are looking for a Hong Kong dollar or U.S. dollar product, and our reputation continues to grow there. And I think we've upset a few of our competitors because in different quarters, we've been bigger than them. Some names that you'll know here and that you're probably talking to. And I think that we have to continue to be competitive and part of that in Hong Kong is going to be pricing. And that's okay as long as we're still continuing to make a margin that's acceptable to us that is a good return on capital, and we believe we're doing that.

Mario Mendonca

analyst
#61

The reason why this is so relevant to me is if it was a particular if there was something special about the quarter, then my -- I'll be inclined to assume that these CSM margins return to what they have been in the past, which, of course, then drives your CSM and drive the earnings. So it does matter if this quarter was special in some way from a pricing perspective. And what I can gather from what you've just said KEvin is you did need to do this quarter, but you shouldn't assume that you have to go to this extent every quarter. Is that right?

Kevin Strain

executive
#62

It's not a quarter thing. I think Majit is talking about, it is reacting to the market as they grow, so it wasn't specific to this quarter and we're actually in really good -- I think we're in a really good place, actually.

Mario Mendonca

analyst
#63

I interpret that to mean that the CSM margin could remain low or lower than it has been in the past because the environment has changed. I mean that's the only way I can iterpret that response, but -- perhaps I can go to something else.

Kevin Strain

executive
#64

Yes. I think the the lot you're seeing right now are kind of a corporate Mario current and competitive environment. Obviously, that could change 1 more. But I think if you are to look at for the next quarter, I think levels are appropriate.

Mario Mendonca

analyst
#65

That makes that's precisely the point that feeds into how you grow this company, so that's why I'm asking the question. So moving on to stop loss for a moment, your growing stop loss at a really nice pace here. Is this the kind of business that benefits from consolidation? Or is it -- are you better off watching your competitors deemphasize the business than taking share of margins you prefer? Is this an organic story? or doesn't lend itself a deal?

David Healy

executive
#66

Mario, it is David, thanks for the question. So we are very proud of our differentiated capabilities in the marketplace, and we're very focused on organic growth. We think that that is forward and the proprietary advanced analytic models, the underwriting discipline we have, the risk evaluation that is new to me to us is really unique in the marketplace and is helping to differentiate us in the short duration business. So we feel like we can write this business to continue to grow and find opportunities to take share as the market continues to grow.

Mario Mendonca

analyst
#67

It just sounds to me that there's no point in doing deals in this space. You can just take it underarm because we are repricing over here this anyway and that's....

Unknown Executive

executive
#68

It's not a priority, it is not a priority.

Kevin Strain

executive
#69

This is Kevin again. That's exactly how I look at it. I think we're a big player. It is genuinely replaceable. We have great capabilities, and we're able to win business over time and that is the focus there.

Mario Mendonca

analyst
#70

Finally, government or Medicaid sales in dental were 0 this quarter. Is that the new number of focus on the -- like this business is no longer for Sun Life. Is that right?

Unknown Executive

executive
#71

Well, as I said earlier, Mario, we just continue to focus on selling and retaining profitable business that meet our long-term earnings margin targets. Now government sales have been and will continue to be lumpy. And so we do have a pipeline of course, but we will take a different approach to make sure that anything we do right and it is going to be helpful to us as we get back our earnings over time.

Operator

operator
#72

We have no further questions at this time. This concludes today's conference call. You may disconnect your lines. Thank you for participating, and have a pleasant day.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Sun Life Financial Inc. transcript — plus 251,000+ transcripts from 12,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Sun Life Financial Inc. earnings transcripts and 251,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.